XML 20 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
7. Common Stock (Details Narrative) (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Options Exercisable 1,079,500    
Weighted average grant date fair value of non-vested options $ 0.94    
weighted average grant date fair value of vested options $ 0.87    
Total compensation cost recognized for share-based payment arrangements     $ 42,157
Tax Benefit     16,698
Total compensation cost related to non-vested options 126,233    
Employee Stock Option [Member]
     
Employee stock options granted 361,000 2,000,000 491,000
Options exercised (60,000) (50,000) 0
Options forfeited (75,000) (50,000) (20,750)
Weighted average grant date fair value of employee stock options granted 0.58 1.04  
Total compensation cost recognized for share-based payment arrangements 107,882 105,659  
Tax Benefit 42,732 41,841  
Series B Preferred Stock [Member]
     
Issued Series B Preferred Stock   825,000 825,000
Outstanding Series B Preferred Stock   $ 825,000 $ 825,000
Conversion price of common stock   $ 2.25 $ 2.25